DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 1ENVARSUS XR
02 2METHYLPHENIDATE HYDROCHLORIDE
03 2METOPROLOL SUCCINATE
04 1TRAMADOL HYDROCHLORIDE
01 176862
02 177298
03 1200491
04 1206406
05 1210818
06 1213473
01 5No
02 1Yes
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Drug : METHYLPHENIDATE HYDROCHLORIDE
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 213473
Country : US
Patented : No
Drug : METOPROLOL SUCCINATE
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 77298
Country : US
Patented : No
Drug : METOPROLOL SUCCINATE
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 76862
Country : US
Patented : No
Drug : METHYLPHENIDATE HYDROCHLORIDE
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 210818
Country : US
Patented : No
Drug : TRAMADOL HYDROCHLORIDE
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 200491
Country : US
Patented : No
Drug : ENVARSUS XR
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 206406
Country : US
Patented : Yes
